Aignostics raises €31.4M Series B round
29 October 2024· Berlin, Germany· health, biotech, ai, industrial_software, b2b, pure_software
The funding will be used to build new product offerings for biopharmaceutical clients, fuel growth within the United States, and develop leading foundation models for pathology in collaboration with Mayo Clinic.
Investors
LeadATHOS
Also participating
High-Tech GründerfondsCarma FundWellington PartnersIBB VenturesBoehringer Ingelheim Venture FundMayo Clinic
About Aignostics
Stage
Series B
Headquarters
Berlin, Germany
Founded
2020
Team Size
51–200
Sectors
healthbiotechaiindustrial_softwareb2bpure_software